FIGURE 4.4 Diagram of execution and accountability in a capabilities-based process.
so that the process considers both innovation and technical feasibility—the art of the possible and the art of the probable (see “Maintaining a Connection to the End User”). Depending on the urgency, difficulty, and capability base, decisions should be made about the degree of specification needed before a research-development-acquisition (R-D-A) process begins. Specifications should consider whether or not 100% survivability is needed or possible.
From Specification to the Research-Development-Acquisition Process
The R-D-A process is well established within DoD, and many elements of the established process are adequate for the CBDP. For the R-D-A process to be effective for the medical countermeasures program, however, R-D-A should be done as a team approach with end-to-end involvement, including regulatory processes considered in the earliest phases.
Once specifications are derived based on a solid analysis of capability gaps and tradeoffs, then the maturity of existing products can be assessed against the specification to determine whether new, innovation research is necessary (Research) or whether development or furthering of an exist-